CompletedPhase 3

Six vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer

NCT00615602

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

University Hospital of Crete

Heraklion, Crete, Greece

+9 additional locations

Save this trial

University Hospital of CreteHeraklion, Crete, Greece
University General Hospital of Alexandroupolis, Dep of Medical OncologyAlexandroupoli, Greece
"IASO" General Hospital of Athens, 1st Dep of Medical OncologyAthens, Greece
"Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal MedicineAthens, Greece
"Marika Iliadis" Hospital of Athens, Dep of Medical OncologyAthens, Greece
401 Military Hospital of AthensAthens, Greece
Air Forces Military Hospital of AthensAthens, Greece
State General Hospital of Larissa, Dep of Medical OncologyLarissa, Greece
"Metaxa's" Anticancer Hospital of Piraeus, 1st Dep of Medical OncologyPiraeus, Greece
"Theagenion" Anticancer Hospital of Thessaloniki, 2nd Dep of Medical OncologyThessaloniki, Greece